Status:
UNKNOWN
Comprehensive CT-guided vs Echo-fluoroscopy-guided Strategy in the Left Atrial Appendage Occlusion
Lead Sponsor:
RenJi Hospital
Conditions:
Cardiology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Percutaneous left atrial appendage occlusion (LAAO) is an increasingly used alternative to oral anticoagulation in patients with nonvalvular atrial fibrillation (AF). Transesophageal echocardiography ...
Detailed Description
The PERIVISION-LAAO study will be a prospective, multi-center and randomized trial designed to investigate the effect and safety of perimeter obtained by 3D-CTA versus diameter obtained by traditional...
Eligibility Criteria
Inclusion
- Clinical diagnosis of atrial fibrillation Disease
- Age \>18years
- CHA2DS2-VASc scores ≥ 2
- And at least one of the following indications: (a) HAS- BLED scores ≥ 3; (b) intolerance to long-term OAC; (c) stroke, TIA or thromboembolism even under OAC treatment
Exclusion
- GFR \<50 mL/min/1.73 m2
- Thrombus in LA and LAA
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT04913207
Start Date
August 1 2020
End Date
December 31 2023
Last Update
June 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Jiao Tong University, School of Medicine, Affiliated Ren Ji Hospital
Shanghai, Shanghai Municipality, China, 200127